skip to main |
skip to sidebar
Triple Pink Foundation once again is partnering with Dunkin’ Donuts® to present a unique breast cancer awareness event - Munchkins® & Mammograms. The event will take place on Saturday, May 10, 2014 at the Brookhaven Dunkin’ Donuts, 4040 Peachtree Street NE, Atlanta 30319.
We are so busy during the week with work and family that our health usually takes a backseat. Munchkins® & Mammograms gives you a convenient way to get your annual mammograms. And it's the best Mother's Day gift you can give to yourself!
Each woman who receives a mammogram also will receive free Munchkins®. Think of it as a way to sweeten the experience.
The mammograms will be performed by St. Joseph’s Mobile Mammography Coach from 9:00 a.m. until 3:00 p.m. The service is provided at no or low cost to patients with approved insurance providers. Most insurance providers are accepted by St. Joseph’s. Pre-registration must be completed by April 18, 2014.
For more information and to schedule an appointment, contact Triple Pink at: rsvp@triplepink.org.
 |
| Photo Credit: Genetech |
The FDA recently approved a new drug developed by Roche pharamaceuticals for the treatment of HER-2 positive breast cancers. Perjeta was accepted by the FDA for priority review, indicating that the drug presents a significant advantage over existing treatments. During clinical trials for advanced breast cancer, the drug significantly delayed the cancer from worsening, compared to the existing standard of care.
In addition to the approved Perjeta, Roche also is developing T-DM1, which is designed to combine a type of chemotherapy to Herceptin. The drug is in Phase III trials and is being developed for treatment of HER-2 positive breast cancers.
Read more: http://www.cbsnews.com/8301-504763_162-57451906-10391704/fda-approves-perjeta-for-late-stage-breast-cancer/
